![David E. Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David E. Clark
Chief Tech/Sci/R&D Officer at Pulmagen Therapeutics (Synergy) Ltd.
Profile
David E.
Clark is Director of CADD & Information Services for Argenta Discovery Ltd.
Previously, he worked with the CADD Group of Aventis and Rhone-Poulenc Rorer.
Dr. Clark received a degree from the University of Oxford and an MSc and a PhD from the Department of Information Studies at the University of Sheffield.
David E. Clark active positions
Companies | Position | Start |
---|---|---|
Pulmagen Therapeutics (Synergy) Ltd.
![]() Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Former positions of David E. Clark
Companies | Position | End |
---|---|---|
Rhone-Poulenc Rorer, Inc.
![]() Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
Aventis Behring | Corporate Officer/Principal | - |
Training of David E. Clark
University of Oxford | Undergraduate Degree |
The University of Sheffield | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Pulmagen Therapeutics (Synergy) Ltd.
![]() Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
Aventis Behring | Health Technology |
Rhone-Poulenc Rorer, Inc.
![]() Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
- Stock Market
- Insiders
- David E. Clark